Tumor volume in prostate cancer and serum prostate-specific antigen. Analysis from a kinetic viewpoint.
暂无分享,去创建一个
[1] G. Thomas. Calculus and Analytic Geometry , 1953 .
[2] Brian W. Kernighan,et al. The C Programming Language , 1978 .
[3] M. Coptcoat,et al. The release of free prostate specific antigen into the circulation during transurethral resection of the prostate: kinetics and interaction with serum protease inhibitors. , 1998, British journal of urology.
[4] D. Chan,et al. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease. , 1992, Cancer research.
[5] Half-life determination of serum free prostate-specific antigen following radical retropubic prostatectomy. , 1996, Urology.
[6] H. Lilja,et al. Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum. , 1998, Urology.
[7] T. Wheeler,et al. Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer. , 1994, The Journal of urology.
[8] S. Loening,et al. Elimination of Serum Free and Total Prostate-Specific Antigen after Radical Retropubic Prostatectomy , 1997, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[9] S. Loening,et al. ACT-PSA and complexed PSA elimination kinetics in serum after radical retropubic prostatectomy: proof of new complex forming of PSA after release into circulation. , 2000, Urology.
[10] T. Stamey,et al. Observations on the doubling time of prostate cancer. The use of serial prostate‐specific antigen in patients with untreated disease as a measure of increasing cancer volume , 1993, Cancer.
[11] W. Catalona,et al. Effects of rectal examination, prostatic massage, ultrasonography and needle biopsy on serum prostate specific antigen levels. , 1992, The Journal of urology.
[12] A. Partin,et al. Clearance rate of serum‐free and total PSA following radical retropubic prostatectomy , 1996, The Prostate. Supplement.
[13] A. Semjonow,et al. Half-life of prostate-specific antigen after radical prostatectomy: the decisive predictor of curative treatment? , 1992, European urology.
[14] M. Dauge,et al. Clearance of serum PSA after open surgery for benign prostatic hypertrophy, radical cystectomy, and radical prostatectomy , 1995, The Prostate.
[15] J. Oesterling,et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.
[16] L. Boccon‐Gibod,et al. Clearance of Free and Total Serum PSA after Prostatic Surgery , 1998, European Urology.
[17] G. Andriole. Serum prostate-specific antigen: the most useful tumor marker. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] P. Humphrey,et al. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. , 1996, The Journal of urology.
[19] T. Stamey,et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. , 1988, The New England journal of medicine.
[20] J. Pontes,et al. Prognostic implications of disappearance rate of biologic markers following radical prostatectomy. , 1990, Urology.
[21] A Grünert,et al. Serum half-life time determination of free and total prostate-specific antigen following radical prostatectomy--a critical assessment. , 1999, Urology.